Related Experiment Video
Updated: Jan 21, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Bone mineral density and its influencing factors in children with idiopathic nephrotic syndrome: a prospective
Indar K Sharawat1, Lesa Dawman1, Merabhai V Kumkhaniya1
1Junior Resident, Department of Pediatrics, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.
Insights
Children with idiopathic nephrotic syndrome (INS) treated with glucocorticoids face risks to bone health. Low vitamin D levels, not steroid dose, were found to be the primary predictor of reduced bone mineral density in these patients.
Area of Science:
- Pediatric Nephrology
- Endocrinology
- Bone Metabolism
Background:
- Idiopathic nephrotic syndrome (INS) in children is primarily treated with glucocorticoids.
- Glucocorticoid therapy can lead to adverse effects on bone metabolism, including decreased bone mineral density (BMD).
- Children with INS are at increased risk for skeletal complications due to the disease and its treatment.
Purpose of the Study:
- To investigate the factors influencing bone mineral density (BMD) in children with idiopathic nephrotic syndrome (INS).
- To identify predictors of low bone mineral density (BMD) in pediatric patients undergoing glucocorticoid therapy for INS.
Main Methods:
- A cohort of 60 children diagnosed with INS was studied.
- Patients were categorized into two groups based on relapse frequency and steroid dependency.
- Bone mineral density (BMD) of the lumbar spine was assessed using dual-energy X-ray absorptiometry (DXA).
Main Results:
- Mean BMD Z-scores were compared between the patient groups.
- Univariate analysis revealed significant correlations between BMD Z-scores and cumulative steroid dose, serum vitamin D levels, and calcium supplementation.
- Multivariate analysis identified serum vitamin D level as the sole significant predictor of low BMD Z-scores.
Conclusions:
- Serum vitamin D levels are a critical factor in maintaining bone mineral density (BMD) in children with idiopathic nephrotic syndrome (INS).
- Monitoring and optimizing vitamin D status may be crucial for preventing low bone mineral density (BMD) in pediatric INS patients.
- Further research into targeted supplementation strategies is warranted.
Abstract:
Glucocorticoids are first-line therapy for children with idiopathic nephrotic syndrome (INS). These children are at risk of deranged bone metabolism and low bone mineral density (BMD). We studied 60 children with INS and divided them into two groups. Group 1 included 21 children (initial and infrequent relapsing) and group 2 included 39 children (frequent relapsing, steroid dependent and steroid resistant). Dual-energy X-ray absorptiometry of the lumbar spine was performed to assess BMD. Mean BMD Z-score was compared in both groups; this correlated significantly on univariate analysis with cumulative steroid dose, serum vitamin D levels and calcium supplementation. However, on multivariate analysis, serum vitamin D level was the only factor significantly predictive of low z-score.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Bioavailability: Influencing Factors
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Factors Influencing Microbial Growth: pH

